SCHEMBL29951799

SCHEMBL29951799

COc1cc(C)cc(C=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP2A6 P11509 2/20 0.50
CYP1A1 P04798 3/20 0.48
CYP1B1 Q16678 3/20 0.48
ESR1 P03372 2/20 0.41
NQO2 P16083 2/20 0.41
CYP1A2 P05177 2/20 0.41
TSHR P16473 1/20 0.41
ABL1 P00519 1/20 0.41
TTR P02766 1/20 0.41
ABCB1 P08183 1/20 0.41
ALOX5 P09917 1/20 0.41
BCR P11274 1/20 0.41
CYP19A1 P11511 1/20 0.41
PTGS2 P35354 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
AHR P35869 1/20 0.41
TUBA1B P68363 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5883049 1.00 ALDH1A1 (0.50) ALDH1A1CYP2A6CYP1A1CYP1B1ESR1
SCHEMBL1663786 0.86 ALDH1A1 (0.58) ALDH1A1CYP2A6CYP1A1CYP1B1ESR1
SCHEMBL228003 0.86 CYP1A1 (0.64) ALDH1A1CYP2A6CYP1A1CYP1B1ESR1
Water SCHEMBL28227114 0.84 CYP1A1 (0.61) ALDH1A1CYP2A6CYP1A1CYP1B1ESR1
Formic Acid Methyl Ester SCHEMBL28071788 0.80 CYP1A1 (0.56) ALDH1A1CYP2A6CYP1A1CYP1B1ESR1
SCHEMBL16362233 0.80 CYP1A1 (0.77) CYP1A1CYP1B1ESR1NQO2CYP1A2
SCHEMBL16958243 0.78 CYP1A1 (0.48) ALDH1A1CYP1A1CYP1B1ESR1NQO2
SCHEMBL378297 0.78 CYP1A1 (0.58) ALDH1A1CYP2A6CYP1A1CYP1B1NQO2
SCHEMBL31618743 0.78 CYP1A1 (0.48) ALDH1A1CYP1A1CYP1B1ESR1NQO2
SCHEMBL29958196 0.78 CYP1A1 (0.58) ALDH1A1CYP2A6CYP1A1CYP1B1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP disclosed
EP-4626891-A1 FUSED PYRIMIDINES AS MASP-2 INHIBITORS Omeros Corporation (US) 2025-10-08 EP disclosed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO disclosed
WO-2024118840-A1 FUSED PYRIMIDINES AS MASP-2 INHIBITORS OMEROS CORPORATION (US) 2024-06-06 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed